The virology market is projected to reach US$ 5,276.48 million by 2028 from US$ 4,108.27 million in 2021; it is expected to register a CAGR of 3.6% from 2021 to 2028.

Virology is among the significant sections of the healthcare system. It has an extensive application in the vaccine development, diagnostics, treatment therapies, and others. The  virology market players are constantly involved in product innovations and developments to sustain the competition in the market. They explore various scopes for product innovations. For instance, for COVID-19, market players are investing significantly in the development of vaccines, testing kits, and other related products and services. Below are a few of the market developments related to the virology market.

• In August 2021, the U.S. Food and Drug Administration (FDA) approved the first COVID-19 vaccine known as the Pfizer-BioNTech COVID-19 Vaccine. It will be marketed as ComiRNAty (Koe-mir’-na-tee). The vaccine is intended to prevent COVID-19 disease in individuals aged 16 years and above. It is also available under emergency use authorization (EUA).
• In April 2021, CerTest Biotec launched its CE-marked COVID-19 diagnostic test for the BD MAX System.
• In May 2020, Bio-Rad received FDA approval for emergency use authorization for the COVID-19 total antibody test.
• In May 2020, Aalto Bio Reagents launched New Recombinant Eukaryotic SARS-CoV-2 S1-S2 Spike Proteins.
  

Thus, such active participation of the market players through product innovations and governments support in different countries bolsters the growth of the virology market. 

Customize Research To Suit Your Requirement

We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.

Get 10% FREE CUSTOMIZATION

Virology Market: Strategic Insights

Virology Market

• 
  CAGR (2021 - 2028)

  3.6%
• Market Size 2021
  US$ 4.11 Billion
• Market Size 2028
  US$ 5.28 Billion

Market Dynamics

GROWTH DRIVERS

• XXXXXXX
• XXXXXXX
• XXXXXXX

FUTURE TRENDS

• XXXXXXX
• XXXXXXX
• XXXXXXX

OPPORTUNITIES

• XXXXXXX
• XXXXXXX
• XXXXXXX

Key Players

• Abbott
• Johnson And Johnson Services, Inc.
• F. HOFFMANN-LA ROCHE LTD.
• THERMO FISHER SCIENTIFIC INC.
• QIAGEN
• Illumina, Inc.
• Siemens AG
• Glaxosmithkline Plc
• Abbvie Inc.

Regional Overview

• North America
• Europe
• Asia-Pacific
• South and Central America
• Middle East and Africa

Market Segmentation

Type

• Diagnostic Test
• Viral Infection Controlling Techniques
• Antiviral Therapeutics
• Interferons

Application

• Skin and Soft Tissue Infections
• Respiratory Tract Infections
• GI Tract Infections
• Sexually Transmitted Diseases
• Urinary Tract Infection
• Others

End User

• Hospitals
• Diagnostic Laboratories
• Pharmaceutical and Biotechnological Companies
• Research and Academic Institutes

Geography

• North America
• Europe
• Asia Pacific
• Middle East and Africa
• South and Central America

Download Free Sample

   Buy Now   

• Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.

 

Market InsightsGrowing Adoption of Minimally Invasive and Non-Invasive Esthetic Procedures Drive Virology Market Growth

Viruses such as human immunodeficiency virus (HIV), flu virus, zika virus, Ebola virus, SARS-CoV-2, and poliovirus infect large population across the world. As the virus mutate and evolve continuously, drug resistance becomes a major challenge in viral infection management among the humans and animals. A virus transmits through various media based on its type. For instance, some viruses cause respiratory viral diseases, such as flu, common cold, and respiratory syncytial virus infection, and they are transmitted via droplets generated through coughing or sneezing, whereas some gastrointestinal viral diseases are transmitted through direct contact with the feces of infected people or through contaminated food or water. As per the UNAIDS  Global HIV & AIDS statistics, more than 37.7 million people across the world were infected by HIV in 2020.

The International Committee on Taxonomy of Viruses (ICTV) declared the novel coronavirus that caused COVID-19 as Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) in February 2020. The virus has undergone mutation a couple of times since its outbreak, which has added to the severity of the COVID-19 pandemic. For instance, as per the COVID-19 tracker data by the Centers for Disease Control and Prevention (CDC), as of August 2021, the seven-day case rate per 100,000 is 299.4, and over 164,952 new cases are reported in the US. Moreover, as per the European Centre for Disease Prevention and Control, as of August 2021, the total count of COVID-19 cases reached ~36,307,572 patients in the European Economic Area (EEA). Thus, such rising prevalence of viral infections is driving the growth of the virology market. 

Virology Market Report Scope

Download Free Sample

   Buy Now   

• Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.

 

Type-Based Insights

Based on type, the virology market is further segmented into diagnostic tests, viral infection controlling techniques, antiviral therapeutics, and interferons. In 2021, the diagnostic test segment is expected to hold the largest share of the market, and viral infection controlling techniques segment is estimated to register the highest CAGR during 2021–2028. 

Application-Based Insights

Based on application, the market is segmented into skin and soft tissue infections, respiratory tract infections, GI tract infections, sexually transmitted diseases, urinary tract infection, and others. In 2021, the respiratory tract infections segment is estimated to hold the largest share of the market, and it is expected to register the highest CAGR during 2021–2028.
Companies operating in the virology market emphasize on adopting the product innovations strategy to meet the evolving customer demands across the world, which also permits them to maintain their brand name in the global market. 

Virology Market – Segmentation

 

By Type

• Diagnostic Test
  • DNA Virus Testing
  • RNA Virus Testing
  • Others
• Viral Infection Controlling Techniques
  • Active Prophylaxis
  • Passive Prophylaxis
• Antiviral Therapeutics
  • Virucidal Agents
  • Antiviral Agents
  • Immunomodulators
• Interferons 

By Application

• Skin and Soft Tissue Infections
• Respiratory Tract Infections
• GI Tract Infections
• Sexually Transmitted Diseases
• Urinary Tract Infections
• Others

By End User

• Hospitals
• Diagnostic Laboratories
• Pharmaceutical and Biotechnological Companies
• Research and Academic Institutes

By Geography

• North America
  • US
  • Canada
  • Mexico
• Europe
  • France
  • Germany
  • Italy
  • UK
  • Spain
  • Rest of Europe
• Asia Pacific
  • China
  • India
  • South Korea
  • Japan
  • Australia
  • Rest of APAC
• Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of MEA
• South and Central America
  • Brazil
  • Argentina
  • Rest of SCAM

 

Company Profiles

• Abbott
• Johnson & Johnson Services, Inc.
• F. Hoffmann-LA Roche Ltd.
• Thermo Fisher Scientific, Inc.
• Qiagen
• Illumina, Inc.
• Siemens AG
• GlaxoSmithKline Plc
• Gilead Sciences, Inc.
• AbbVie, Inc.pyright names given on respective websites.